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STUDIES IN HUMANS
Stakeholders’ perception of the nutrition and health claim regulation
Alie de Boer and Aalt Bast
Department of Toxicology, Maastricht University, Maastricht, The Netherlands
Abstract
In 2007, the Nutrition and Health Claim Regulation (NHCR) entered into force, which required
scientific substantiation of health claims. In the field of antioxidants, most proposed claims
were negatively assessed by the European Food Safety Authority (EFSA). This study reviews the
perception of the NHCR of 14 Dutch stakeholders to unravel the grounds for disproving the
putative health claims. Most claims are shown to be refused based on the quality of scientific
substantiation, due to usage of scientific methods on which no consensus has been reached
and the differences in expectations and requirements. Three themes exemplify the need for
improvement in applying the NHCR: (i) enforcement; (ii) methodology; and (iii) perceived
impact of the NHCR. With highly diverging perceptions of stakeholders, the current
effectiveness of the NHCR can be questioned. The views of different stakeholders on these
themes help to focus the discussion on the NCHR in capturing health effects.
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Introduction
Following the reform of European food law in the aftermath of the
bovine spongiform encephalopathy (BSE) crisis, a new regulatory
framework dealing with nutrition and health claims entered into
force in the EU in 2007: the Nutrition and Health Claim
Regulation1 (NHCR) (Gilsenan, 2011; Moors, 2012). The NHCR
aims to protect consumers from misleading by incorrect infor-
mation and false claims by ensuring that proposed claims are
scientifically substantiated. Moreover, the NHCR is intended to
improve the free movement of goods in the internal market by
harmonizing the various national regulations of Member States
(European Parliament and the Council, 2006; Gilsenan, 2011;
Hoad, 2011; Moors, 2012). The use of a claim is permitted or
refused by the European Commission (EC), after consulting the
expert opinion of the European Food Safety Authority (EFSA).
EFSA is the independent agency advising the EC on the accuracy
of the scientific basis of a claim through a set of different criteria
(EFSA, 2014a,d).
The NHCR regulates both nutrition and health claims.
Nutrition claims describe the nutritional properties of the
ingredient or food product. Health claims state the relationship
between the ingredient or food product and a beneficial effect on
health (European Parliament and the Council, 2006). Health
claims can be divided into three categories: (i) article 13.1 claims:
general function claims, implying a health benefit based on
scientific evidence (EFSA, 2012); (ii) article 13.5 claims: new
function claims, implying a health benefit based on newly
developed scientific evidence (EFSA, 2014c); and (iii) article
14 claims: claims on (a) the reduction of disease risk or on (b)
children’s development and health (EFSA, 2014b; European
Commission, 2013; European Parliament and the Council, 2006).
Approved article 13.1 and 13.5 claims are made public in the
annex to Regulation 432/20122 (EFSA, 2012). New EC-
authorized article 13.5 claims are continuously added to this list
(Verhagen et al., 2010). Currently, the EC authorized 233 claims
(European Commission, 2012). EFSA considered nearly all
proposed article 13.1 claims on antioxidants were not substan-
tiated satisfactorily, leading the EC to decline these claims (de
Boer et al., 2014; European Commission, 2013). Only eight
claims on antioxidant activity received a positive advise and were
subsequently authorized by the EC, viz. seven claims on vitamins
and minerals, one claim on olive oil polyphenols (European
Commission, 2013). Positive opinions from EFSA on water-
soluble tomato concentrate (NDA Panel EFSA, 2009, 2010) and
on cocoa flavonoids (NDA Panel EFSA, 2012) are not taken into
account here, since the claimed health benefits of these products
are not regarded as consequence of antioxidants as the active
ingredient (de Boer et al., 2014).
Only very few statements about ingredients acting as antioxi-
dant or their health effects are currently allowed (Europe Press
Releases, 2006; European Commission, 2013). In order to unravel
the ground(s) for disproving the putative health claims of all
virtual antioxidants, this study reviews the perception of stake-
holders of the NHCR. This was investigated by conducting semi-
structured in-depth interviews with stakeholders in the
Correspondence: Ms Alie de Boer, MSc, Department of Toxicology,
Maastricht University, P.O. Box 616, 6200 MD Maastricht, The
Netherlands. E-mail: a.deboer@maastrichtuniversity.nl
1Regulation (EC) No. 1924/2006 of the European Parliament and of the
Council of 20 December 2006 on nutrition and health claims made on
foods. Regulation (EC) No. 1924/2006 is amended by Regulation (EC)
No. 107/2008; Regulation (EC) No. 109/2008; Commission Regulation
(EU) No. 116/2010; and Commission Regulation (EU) No. 1047/2012.
2Commission Regulation (EU) No. 432/2012 of 16 May 2012 establishing
a list of permitted health claims made on foods, other than those referring
to the reduction of disease risk and to children’s development and
health. Regulation 432/2012 is amended by Commission Regulation
(EU) No. 536/2013; Commission Regulation (EU) No. 851/2013;
Commission Regulation (EU) No. 1018/2013; and Commission
Regulation (EU) No. 40/2014, adding seven article 13.1 and four article
13.5 claims to the list found in the Annex.
Netherlands, working with functional ingredients and specifically
antioxidant containing ingredients. Following Freeman’s defin-
ition of stakeholders (1984): ‘‘any group or individual who can
affect or is affected by the achievement of the [organization’s]
objectives’’, for the purpose of this four study groups were
identified as stakeholders of the NCHR, viz. industrials (who have
to live up to the requirements following the NHCR for current and
future claims), regulatory experts (either involved in discussions
on the development of the positive list or in enforcing the NHCR),
nutritional scientists (affected by the required standards for
scientific substantiation) and consumer representatives (serving as
spokespersons for consumers, who are facing claims as marketing
statements) (Bremmers et al., 2013; Ernst & Young, 2012;
Freeman, 1984).
Methods
For the purpose of this research a qualitative approach was
followed, since qualitative research gives the opportunity to
extensively explore the experiences of the involved stakeholders
(Ritchie & Lewis, 2003). By conducting semi-structured in-depth
interviews in person it was possible to review the perception of
stakeholders of the NHCR and their attitude about the procedures
surrounding this regulation (DiCicco-Bloom & Crabtree, 2006).
Theoretical framework
Through literature research and obtained expert opinions three
themes were identified, which are expected to influence a
stakeholder’s view on the NHCR: (i) the regulatory act itself;
(ii) the assessment procedure; and (iii) the impact of the
regulation.
Expectations a stakeholder had of the regulatory act during the
drafting process of the NHCR are assumed to influence the
perception, as expectations prior to the occurrence of an event are
described to influence the perception of that event (Oliver, 1980;
Woodruff et al., 1983). In addition, current experience in dealing
with the regulation is expected to affect perception. Since the EC
decision is based on the scientific opinion of EFSA, the
assessment procedure is expected to influence a stakeholder’s
view of the NHCR. Next to that, the credibility of this assessment
process depends partially on transparency and independence of
EFSA (Jensen & Sandøe, 2002; Klintman & Kronsell, 2010;
Kobusch, 2010; Levidow & Carr, 2007; Schreider et al., 2010).
The NHCR aims to stimulate innovation through the use of
approved health claims, and therefore the impact on innovation is
considered in the third variable (European Parliament and the
Council, 2006). Since innovation is highly connected to research, a
stakeholder is expected to link the effect on innovation to the
impact of the NHCR on research (Mansfield, 1991; Nelson, 1993).
Selection of participants
In total, 14 Dutch professionals participated in this study
(Table 1). In line with the theoretical framework set forth
above, the four groups of stakeholders that are affected by the
NHCR through different positions were approached: industrials,
regulatory experts, nutritional scientists and consumer represen-
tatives (Freeman, 1984). Since this study focuses specifically on
the NHCR and processes related to the NHCR and concentrates
on food products containing antioxidants, key players were
identified and by means of purposive sampling invited to
participate in this study (Tansey, 2007). Although this type of
non-probability sampling could limit the generalizability of
results, the number of experts in the field is very limited and to
reach the objective of this study, this methodology is considered
to be appropriate (Lucas, 2014; Tansey, 2007). The identified key
players were invited to participate in the study by e-mail. In this
invitation e-mail, the aim of the study was explained as follows
(translated from Dutch): ‘‘By conducting this research we want to
identify how various stakeholders (industrials, regulatory experts,
nutritional scientists and consumer representatives) perceive the
use of the Nutrition and Health Claim Regulation within the field
of food products containing antioxidants, which aspects are
considered positive and what could be improved’’.
Following the conducted interviews, each interviewee was
asked to suggest possible participants to ensure a sufficient amount
of stakeholders (Tansey, 2007). These individuals were, if not
involved in the study already, contacted to participate. Although
such snowball sampling is suggested to give a higher chance for
participation of experts with more social connections, the small
amount of experts in the field of antioxidants led to the need to
include this type of sampling to ensure sufficient participants to
reach the objective of the study (Lucas, 2014; Tansey, 2007). Even
though most interviewees suggested already participating stake-
holders, new participants were invited until no new findings were
extracted in the data analysis from the conducted interviews
and therefore the point of saturation was reached, leading to
14 participants in this study (Mason, 2010; Tansey, 2007).
Data collection
Semi-structured in-depth interviews with the participants were
based on the theoretical framework (section ‘‘Theoretical frame-
work’’). All interviews were individually conducted in person by
the first author. This set-up gave the possibility to ask in-depth
questions to the interviewees to review their perception of the
NHCR and the procedures surrounding this regulation (DiCicco-
Bloom & Crabtree, 2006). During the interviews, all participating
professionals were confronted with comparable questions.3
Following the introduction, explaining the objective of the
interview, the interviewee was asked how he or she came into
contact with the regulation, to clarify the position of the
interviewee. Secondly, expectations and experience were
addressed, and the objectives of the regulation were discussed.
Subsequently, the perceived impact on innovation and research
was discussed, focusing on the perceived impact within the field
of antioxidants. The interview deliberated on the position of
EFSA, as well as perceived advantages and disadvantages of the
NHCR, again focussing on the field of antioxidants. If there were
problems according to the interviewee which were due to this
regulation, solutions were asked. Finally, the used standards for
scientific substantiation were addressed.
All interviews, which were conducted in Dutch, lasted 30 to
60 min and audio recordings were used to transcribe the
interviews. All participants were requested to correct
transcriptions.
3Due to dynamics of the interviews, three questions were added
throughout the interviews and the order of questions was changed.
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Data analysis
The transcriptions were analyzed through a systematic approach
of directed content analysis to identify key concepts, using the
existing theoretical framework (section ‘‘Theoretical frame-
work’’) (Hsieh & Shannon, 2005). After reviewing the theoretical
framework as well as the aim and research questions of the study,
transcriptions were read intensively and repeatedly. Since the aim
of this study was to identify all relevant issues with the NHCR
raised by interviewees, all presented arguments and issues were
highlighted. Secondly, the highlighted passages were coded with
pre-determined codes, based on the theoretical framework.
Thirdly, new codes were given to passages without a pre-
determined code. Based on these identified concepts and their
relationships, the theoretical framework was adjusted. Finally, by
comparing the initial theoretical framework to the rebuilt
framework and by addressing similarities and differences in
theoretical concepts, the final framework was build (depicted in
Figure 1). All transcriptions were analyzed through this system-
atic approach by two members of the research team to reduce the
possibility of the informed bias raised by the use of a directed
approach (Hsieh & Shannon, 2005). Furthermore, all quotes used
in the paper were anonymized by avoiding the use of any names,
brand names and industry names.
Results and discussion
Figure 1 depicts the identified themes influencing a stakeholder’s
perception of the NHCR. The interviews not only confirmed the
themes described in the theoretical framework, but they also
identified various additional concepts within these themes as
shown in Figure 1. Therefore, the themes comprise the following:
(i) the regulatory act itself; (ii) the assessment procedure; and (iii)
the impact of the NHCR. These themes are discussed below.
Regulatory act
Expectations and experience
Experiences of various interviewees did not live up to their
expectations, leading to disappointment on different aspects of the
NHCR, viz. the assessment procedure, the time needed for
implementation and the current effectiveness. Various industrials
expected, based on publications and presentations previous to the
enactment of the NHCR, the possibility to use graded evidence for
substantiation with probable, possible and convincing evidence
for a claimed effect. This is however not allowed under the
NHCR, only generally accepted or newly developed scientific
evidence establishing a cause and effect relationship is considered
to be sufficient to substantiate a claim (Gilsenan, 2011). The
submitted substantiation was varying strongly: some dossiers
were not based on scientific evidence where others built on high
quality human intervention studies, which exemplifies the differ-
ent expectations of applicants (European Commission, 2013).
A nutritional scientist mentions debatable claims are still on
the market: ‘‘You can still claim almost everything you wanted to
claim earlier, if you use one of the nutrients on the positive list’’.
The consumer representatives also consider the NHCR to be
barely effective: although some non-substantiated claims are
gone, many possibilities to use claims still exist and consumers
can still be misled.
As literature on expectations of performance and consumer
satisfaction explains, these disconfirmed expectations (here:
positive expectations followed by negative experiences) are
shown to result in psychological discomfort and a negative
hedonic state (Anderson, 1973; Festinger, 1962; Greenwald &
Ronis, 1978; Webb & Worchel, 1993).
Objectives
The objectives of the NHCR are prioritized differently by the
interviewees: although all stakeholder groups feel that harmon-
ization of national regulatory provisions is an objective of the
NCHR, industrials and regulatory experts specifically point out
the prevention of medical claims, whereas regulatory experts and
nutritional scientists focus also on scientific substantiation of
claims. The aim of protecting consumers from being misled is
recognized by industrials, nutritional scientists and consumer
representatives. These discrepancies between stakeholders in
prioritization of objectives could be counteracted by providing
more clarity on the factual objectives of the regulatory act.
Although many stakeholders feel the NHCR effectively
protects consumers from being misled, a consumer representative
believes that the NHCR does not live up to its objective:
‘‘Consumers are still misled. Antioxidants are a good theme in
that case, it is quite clear you cannot claim anything on that. The
idea of extra antioxidants in nutrition is actually fully under-
mined, so you cannot claim anything on it, and still you can easily
find these claims’’. In contrast, other interviewees (mainly
industrials) feel the objective of consumer protection is over-
reached by enactment of the NHCR. Accomplishment of other
objectives is also questioned by interviewees, as nutritional
scientists question the stimulation of innovation and competitive-
ness: ‘‘You see companies are investing less in nutrition and
health’’. To meet the various objectives, the need for more
transparency and enforcement is emphasized by many
interviewees.
Enforcement
During the interviews, various issues arise concerning the
enforcement of the NHCR. Considerable uncertainty exists on
enforcement strategies, priorities and capabilities within the
Netherlands as well as in other Member States. Various
interviewees consider the establishment of a level playing field
in the market of functional foods to depend on comparable
enforcement throughout the EU, but the development of such
comparable enforcement is questioned. The uncertainties sur-
rounding the use of claims is exemplified by various stakeholders
by the case of antioxidants, where mentioning the content of
antioxidants is by some considered to be an implicit health claim,
but can also be seen as a nutrition claim.
Increasing compliance by traditional enforcement of laws, with
punishment as important component, as suggested by various
interviewees, is confirmed in literature (Malloy, 2003). However,
Figure 1. Web of themes.
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traditional enforcement poses several limitations: monitoring the
industry highly increases costs and practical difficulties arise in
identifying less visible violations (Malloy, 2003). Various stake-
holders indicate to perceive that detecting violations of the NHCR
is not considered to be a priority for the Netherlands Food and
Consumer Product Safety Authority (NVWA). Therefore, due to
the apparent lack of traditional enforcement methods, traditional
enforcement alone does not seem to be the most suitable way to
enforce this act, although punishment of offences could help to set
an example and increase compliance to the NHCR.
The development of the self-regulating list by Dutch indus-
trials, in consultation with the Ministry of Health, Welfare and
Sports as well as the NVWA, is suggested by several stakeholders
to be a good way to cope with the limited enforcement capacity,
although various interviewees expect self-regulation not to be
sufficient to properly enforce the NHCR (Keuringsraad, 2014;
NVWA, 2014). Self-regulation is described in literature as a
voluntary enforcement mechanism, and this voluntary aspect
could decrease the credibility of the regulation (Haufler, 2001).
Due to weak standards, a lack of transparency and ineffective
enforcement with mild, non-public punishments, self-regulation is
described to fail often, and is therefore considered to serve the
industry rather than the public interest (Gunningham & Rees,
1997). Contrary, when used in a form suitable to the regulation,
self-regulation is shown to be effective. Setting rules and
standards in cooperation with industries and with involvement
of the government could lead to an effective form of self-
regulation, with more flexibility and lower costs of enforcement
(Gunningham & Rees, 1997). Therefore, the use of self-regulation
as a tool in enforcing the NHCR is suggested to be helpful.
Assessment procedure
Several industrials disagree with the current assessment proced-
ure, but do not blame EFSA for the role they were given under the
NHCR. Various nutritional scientists agree: ‘‘Considering the
vagueness of the texts and what is written in the law, EFSA did
everything very well’’. Most interviewees consider EFSA as an
important organization in implementing the NHCR, and regula-
tory experts feel EFSA is also the most appropriate organization
to advise the EC independently and adequately. The quality of
work of EFSA is questioned by some stakeholders, due to the high
workload.
Transparency and independence
Transparency and independence are important aspects influencing
a stakeholder’s view on EFSA. Especially transparency of the
assessment procedure was addressed by stakeholders during the
interviews. Several supplement industrials question the transpar-
ency of EFSA, its procedures and its members, and some
industrials feel the issued opinions are based on unclear criteria.
A supplement industrial believes claims based on textbook
knowledge versus claims based on new evidence are judged
differently: ‘‘We know a lot about the mechanism of action of
vitamins and minerals because deficiencies will cause disease. But
with testing other substances, all patient studies are excluded’’. In
contrast, a food industrial recognizes EFSA as transparent and
objective. Also a consumer representative feels that members of
EFSA work independently to build good dossiers, and uniformity
and transparency of opinions as well as handling of the dossiers are
increased. Since transparency is shown to influence the credibility
of assessments as here the procedure of reviewing scientific
substantiation of a health claim, increased transparency of
documents as scientific opinions will increase trust and legitimacy
of EFSA and the following risk-management decisions of the EC
(Klintman & Kronsell, 2010; Kobusch, 2010; Schreider et al.,
2010). It will also decrease uncertainty and will improve the
required decision-making time and public confidence in the
processes (Frewer & Salter, 2002; Moors, 2012). EFSA and the EC
attempted to improve transparency by developing guidance
documents and by publishing various documents as agendas,
minutes and opinions of the scientific committee and all panels
(Ernst & Young, 2012; European Parliament and the Council,
2002; Finardi et al., 2012; Kobusch, 2010; Silano & Silano, 2008).
Increasing transparency even more could disrupt the stability and
credibility of EFSA: publishing minority opinions and expert
disagreements could alarm the public or could serve as ammuni-
tion for objectors (Finardi et al., 2012; Levidow & Carr, 2007).
Although a regulatory expert feels the members of panels of
EFSA will always be criticized on their independence, since
experience in the field of nutrition research or food industry is
necessary to evaluate health claims, during the interviews little
was commented on the independence of EFSA. The efforts to
improve independence of both EFSA and its members, by
describing the independent position of board members and
scientists involved in EFSA, therefore seem to pay off (Finardi
et al., 2012; Klintman & Kronsell, 2010).
Methodology
Some supplement industrials consider the used assessment
criteria to be problematic: ‘‘Due to this regulation you, as an
entrepreneur, are not allowed to use traditional knowledge to put
information on your package’’. The nutritional scientists agree
that the substantiation criteria are hard to live up to, especially for
the industry. However, a regulatory expert feels that EFSA’s
assessment procedure raised the standards for research: ‘‘EFSA is
actually a huge peer review process. (. . .) EFSA or the regulation
instigated the evaluation of a lot of these criteria and made them
more explicit’’.
The different interviewees do not agree on the effect of
antioxidants, but believe antioxidants should not be characterized
by antioxidant status of products or plasma. As emphasized by a
regulatory expert: ‘‘Most biomarkers in the field of antioxidants
are not valid. Therefore you should not use them, because if EFSA
sees these invalid biomarkers being used in a study, it will be
rejected’’. This exemplifies the need to discuss used methodol-
ogies in nutrition research, as brought up by various stakeholders
in the interviews. The high standards used by EFSA in evaluating
scientific substantiation of health claims and the explicit need for
human data are complimented by most interviewees, although
some supplement industrials feel that the standards are too strict
and too rigorous. Requiring the substantiation of health effects in
an already healthy population is considered to reflect a pharma-
cological approach, which is also seen by a nutritional scientist
and various food industrials. As explained by a nutritional
scientist: ‘‘With respect to antioxidants, we should be striving for
good tests which are indicative for health. At the same time it
should be made clear that a good outcome does not imply five
more healthy years’’. Another nutritional scientist feels that the
current approach highly differs from the set-up of dietary
recommendations, where not only scientific evidence but also
eminence (the expert opinion) is considered.
The focus of the current assessment procedure on clinical
biomarkers in human intervention studies is considered to reflect
this pharmacological approach. The possibility to claim that an
antioxidant can protect against oxidative stress, as currently
allowed for copper, was therefore not expected by an industrial
stakeholder: ‘‘Not permitting the use of oxidative stress as a
health outcome would not have surprised me, although I myself
would not consider it to be a final effect’’. This approach, with
focussing on one or few outcome measures, is in literature
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suggested to be more suitable for drug testing than for nutrition
research, where pleiotropic effects elicited by food should be
researched (Bast et al., 2013; Blumberg et al., 2010; Heaney,
2008; Van Ommen & Stierum, 2002; Weseler & Bast, 2012).
Several industrials and nutritional scientists feel new research
methodologies therefore should be developed to test the effect of
nutrition on health, which should be based on a revised definition
of health. The official WHO definition originates from 1948:
‘‘Health is a state of complete physical, mental and social well-
being and not merely the absence of disease or infirmity’’. (WHO,
2006). Today, health is more about the ability to adapt to specific
circumstances and therefore needs a more individual approach
(Editorial, 2009; Huber et al., 2011; Kussmann et al., 2006; van
Ommen et al., 2009; Van Ommen & Stierum, 2002). With a more
accurate definition of health, proper research methodologies can
be developed to measure the effect of nutrition on maintaining
health (Elliott et al., 2007).
Different methods are proposed in literature to ensure such a
personal approach, as using nutrigenomics and phenotyping
individuals (Astley & Elliott, 2007). However, the methodology
considered most suitable by various interviewees to test nutri-
tional effects on health is the challenge test: an experimental set-
up where the system of a subject is put under pressure with a
challenge, and the ability to resist or to recover from the impact is
the marker for health. Examples of such challenge tests are the
oral glucose tolerance test (OGTT), the oral lipid tolerance test
(OLTT) and the postprandial challenge test (PCT) (Pellis et al.,
2012; WHO, 1999). The influence of a food product or functional
ingredient on this disturbance can be studied in this way (Pellis
et al., 2012; van Ommen et al., 2009; Weseler & Bast, 2012).
These tests are considered to show the short-term effect of
nutrition on health more accurately. Therefore, various inter-
viewees expect these tests to be helpful in the future substanti-
ation of health claims.
Suggested adjustments
Various possible adjustments to the assessment procedure are
suggested by several stakeholders, mainly referring to the issue of
botanical claims of which scientific substantiation is not reviewed
yet. Amongst these botanical claims several antioxidant claims
are seen by a stakeholder. These dossiers will not be reviewed
before the MS agree upon the required assessment procedure, on
which the Commission published a discussion paper in 2012
(Mathioudakis, 2013). Many interviewees are disappointed that
these claims are still on hold, and various solutions are offered.
Mainly supplement industrials emphasize these claims should be
assessed differently under the NHCR, in a procedure more
suitable to review the effectiveness of botanicals and which would
allow claims to be based on traditional use (alike medicine). This
is also the point of view of five of 26 MS in the discussion paper
published by the Commission in 2012, which would lead to a
different treatment of botanicals requiring new rules for the use of
these products in foods (Mathioudakis, 2013). However, many
other interviewees, as well as seven other MS described in the
discussion paper, feel these claims should be assessed via the
currently used procedure and no exception should be made for
botanicals compared to other ingredients in foods (Mathioudakis,
2013). These interviewees feel treating botanicals differently
would undermine the NHCR. The position of an interviewee and
expectations on how this issue will be handled is shown to
influence a stakeholder’s view of the NHCR.
Impact
Most interviewees see less innovation is taking place, due to the
high demands and costs required to substantiate a claim. As an
industrial exemplifies with the case of antioxidants: ‘‘Innovation
in and research on antioxidants is not a very interesting field at
the moment. I believe it is faded glory, and consumers are fed up
with it’’. An industrial feels these requirements favor bigger
companies while decreasing innovation possibilities for small-
and medium-sized companies, and a nutritional scientist feels the
NHCR hereby leads to an impoverishment of reviewing health
effects of products, because when assessing a health claim only
one ingredient within a full product is evaluated. Various
interviewees see that firms start to work around the regulation.
These firms are seen to look for loopholes in the regulation by
repositioning their product, e.g. a medicinal product or create
mismatch products (products either (i) not regularly connected to
health bearing a health claim; or (ii) bearing an approved health
claim on one nutrient, but emphasizing this effect on another
ingredient without an authorized health claim). Other firms are
perceived to adopt a defensive position by using different
communication strategies than claims or focussing on different
unique selling points of their product than health.
The number of approved claims is suggested to determine the
competitive landscape: rejection of the majority of claims is
expected to reduce developments in functional foods (Moors,
2012). With the majority of antioxidant claims being rejected, the
perceived reduction in innovation can be explained easily. In order
to stimulate innovation after this round of rejection, the focus
should rather be on new possibilities to assess health claims more
positively (Moors, 2012). Despite the apparent inhibition of
innovation, a consumer representative favors the positive effect of
the NHCR on reducing consumer misleading.
Regarding the impact of the NHCR on research, differing
opinions are expressed by stakeholders: a consumer representative
sees no effect of the NHCR, since research is focussed on dietary
patterns and is not targeted at specific components, where other
interviewees feel the impact is hardly measureable due to the
variance across institutes. Most industrials see less research is
taking place, since it is highly connected to innovation.
Investments in research are considered to be risky because the
probability to get a claim is low, as stated by an industrial: ‘‘When
we started questioning the substantiation of antioxidant claims,
we decided to lose all of them. They are now prohibited to be used
in our company’’. A regulatory expert emphasizes, however, that
lower investments in research could also be due to the economic
crisis. Other interviewees perceive the NHCR to stimulate
research: new research concepts are developed and the established
assessment criteria could serve as motive to perform higher
quality research.
Several interviewees perceive the NHCR negatively affects the
market. A nutritional scientist thinks that companies should stop
complaining but develop a strategy together to deal with the
required costs and time. Another suggested approach to counter-
act the negative effect of the NHCR on the market is to reduce the
number of mismatch products on the market by providing clarity
on the botanicals issue, enforcing the NHCR and introducing
nutrient profiles. These nutrient profiles, nutritional requirements
which must be met by foods bearing claims, are under develop-
ment (EFSA, 2013). Still, a nutritional scientist believes the
market of functional foods is past its prime and although the
influence of the NHCR is considered not to be positive, less will
be invested in this area.
Many supplement industrials feel the NHCR decreases
possibilities to inform consumers about health effects, although
in literature health claims are considered to be a tool to educate
consumers about health and healthy products, and to stimulate
healthy choices in the diet (Mitra et al., 1999; Roe et al., 1999;
van Trijp & Van der Lans, 2007; Williams, 2005). Literature
however questions this educational effect, since consumers do not
DOI: 10.3109/09637486.2014.986071 Stakeholders’ perception of the nutrition and health claim regulation 325
seem to believe statements made by industry (Menozzi et al., in
press; Teisl & Levy, 1997).
Several interviewees notice decreasing interest and trust of
consumers in claims, which is confirmed in literature: less
exposure decreases the acceptance and interest of consumers
(Dean et al., 2012). Trust is suggested by a supplement industrial
to be increased by informing consumers about the authorization
system of claims and the scientific substantiation required, since
consumers – unaware of the current situation – request an
independent institution to assess and approve a claim (Gray,
2013). Although increased trust in health claims due to the NHCR
is expected by various stakeholders, they still question to which
extent the permitted claims are understood.
These conflicting ideas on the effect of the NHCR on
innovation of functional food products and especially of food
products containing antioxidants, as well as the perceived effects
on research, the market and consumers, seem to highly influence a
stakeholder’s perception of the NHCR.
Strengths and limitations
The interviews, carried out in person by the first author, were
conducted with seven industrials, two regulatory experts, three
nutritional scientists and two consumer representatives. The
industry group was large compared to the other stakeholder
groups, but since this group was very diverse and consisted of both
supplement industrials and food industrials, they are not over-
represented in this study. Although the number of interviewees was
relatively small, in the end no new findings were extracted from
the conducted interviews and therefore the point of saturation was
reached. Since the amount of experts in the field of antioxidants
dealing with the NHCR is very limited, selecting participants via
purposive sampling and snowball sampling was considered
appropriate as discussed in the section ‘‘Selection of participants’’.
Still, the focus on food products containing antioxidants of this
study was not fully reflected in the results, since not all
stakeholders focussed solely on food products containing antioxi-
dants. This led to more general answers on the use of the NHCR
in the field of functional foods, with the case of antioxidants more
often used as an example. However, the participating stakeholders
were all experts in the use of the NHCR in their organization and
came into contact with products containing antioxidants directly
and indirectly. Therefore, all interviews were used for data
collection and analysis.
Recommendations for improving the NHCR
The grounds for disproving all virtual identified antioxidant claims
are entailed in Figure 1: (i) the regulatory act itself, including (a)
expectations and experience, (b) objectives and (c) enforcement;
(ii) the assessment procedure, involving (a) transparency and
independence, (b) methodology and (c) suggested adjustments;
and (iii) the impact of the NHCR, including the impact on
(a) innovation, (b) research, (c) the market and (d) consumers.
Strengths of the NHCR
Most interviewed stakeholders are seen to agree upon the need for
the NHCR in protecting consumers from misleading and
harmonizing regulations throughout Europe. Therefore, the
requirement for scientific substantiation of commercial outings
on antioxidant containing food products and other functional
foods are welcomed. The strengths of the NHCR are considered to
be addressing these needs, and similarly the possibility that
consumers’ trust in claims will be increased due to the NHCR is
favorable in the eyes of different stakeholders. Another positive
aspect mentioned by some interviewees is that over time the
transparency of EFSA in the assessment procedure of proposed
claims is highly increased.
Concerns with the NHCR
The main concerns addressed within the interviews involve the
following concepts: (i) enforcement of the NHCR, (ii) method-
ology of scientific substantiation and (iii) perceived impact. Even
though the NHCR entered into force in July 2007 and the list of
approved claims was published in May 2012, substantial uncer-
tainty seems to exist on the enforcement of the NHCR.
Enforcement is considered to be important for the harmonization
throughout Europe, and although no agreement is reached upon
the preferred form of enforcement, its implementation is requested
by several stakeholders.
The assessment procedure as executed by EFSA is highly
debated by various interviewees. The dossiers firstly submitted
are shown to be based on evidence highly varying in scientific
quality, which exemplifies the differences in expectations of
various applicants of the whole procedure. The ideas of
stakeholders on methodology used in nutrition research not only
differ from each other, but also these views seem to be deviating
fundamentally from the use of nutrition research within the
NHCR where apparently a more pharmacological approach is
used in the assessment procedure. This reveals an underlying
issue: how should the effects of nutrition on health be tested; and
how should health be defined?
The effects of the NHCR on innovation, research, the market
and consumers are experienced differently by various stake-
holders. These mostly intuitive effects perceived by a stakeholder
are shown to either negatively or positively affect the perception
of the NHCR. However, currently no accurate facts about this
impact are available.
The case of antioxidants
The identified issues are helpful in explaining the disproval of the
large amount of proposed health claims on antioxidant containing
products. Not only the expected quality of scientific substantiation
appeared to differ highly from the required scientific substanti-
ation, the methods to study antioxidants are also debated and the
health effects of antioxidants might be more subtle than required
under the current assessment procedure of health claims.
Antioxidants seem to be an interesting theme in the enforce-
ment of the NHCR, since where content claims are mostly
considered to be a nutrition claim, claiming antioxidants in a
product can be seen as an implicit – and sometimes prohibited –
health claim. Also innovation and research on antioxidants, as
well as on the market of antioxidant containing products and
consumer perception thereof are suggested to be highly
influenced by the entry into force of the NHCR, which could
explain opinions of stakeholders on the NHCR (either positive or
negative, depending on their view on the effects of antioxidants).
Suggestions for improvement
Next to explaining the disproval of most proposed health claims
on antioxidants, the identified strengths and weaknesses give the
opportunity to identify specific aspects to improve. Directly
related to the regulatory act itself is the enforcement of the
NHCR, on which clarification of actions of Member States could
shed light. The issue of botanical claims should be resolved by the
European Parliament and the Commission, to ensure fair compe-
tition on the market of functional foods and to enhance the
effectiveness of the NHCR.
However, most improvements do not follow directly from
problems with the NHCR itself, but from the public debate
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about the NHCR as well as from issues with procedures
developed under the regulatory act. The perceived impact of the
NHCR on innovation, research, the market and consumers is seen
to highly influence a stakeholder’s perception of the NHCR.
Currently, this discussion seems to be extremely driven by
instincts and intuition of experts in the field, without being based
on facts. To ensure this debate reflects the actual situation,
quantitative measurements of the impact of the NHCR are
required. These effects could be studied by comparing resources
allocated to both innovation and research in different institutes
before the entry into force of the NHCR to the current situation,
and numbers on the market of antioxidant containing food
products and other functional foods can be compared with
numbers of the period before the NHCR. Nevertheless, consumer
effects are more difficult to measure quantitatively. The impact of
the NHCR on consumers could be assessed by reviewing their
attitude and willingness to pay towards functional foods carrying
specific claims.
The main issue identified through these interviews with
experts in the field of antioxidants is the assessment procedure,
with pointing out methodological problems next to the distinct
ideas in science about health effects of nutrition. Although
antioxidants serve as a good model, these problems do not seem to
arise solely in this field. To improve both dossiers building and
the assessment procedure, new methodology on how to assess
health effects elicited by antioxidants and other nutritional
substances should be developed and implemented, following
from scientific consensus reached on the definition of health.
Conclusion
The NHCR was created to regulate commercial outings of health
benefits elicited by nutrition. This research was initiated after
most proposed antioxidant claims were seen to fail the assessment
procedure. To unravel the grounds for disproving the putative
health claims, the perception of stakeholders of the NHCR was
reviewed by conducting semi-structured in-depth interviews with
14 stakeholders. Most proposed antioxidant claims are seen to be
refused based on the quality of scientific substantiation, not only
due to the use of scientific methods on which no consensus has
been reached, but also due to the differences in expectations of
submitters versus requirements of the assessors. Although most
stakeholders welcome the NHCR as means to fight consumer
misleading and harmonize international regulations, a clear need
for improvement in the application of the NHCR is shown. An
independent assessment of the impact of the NHCR on innov-
ation, research, the market of antioxidants and functional foods,
and consumer acceptance of nutrition and health claims, next to
more clarity on enforcement procedures within Member States
would help to improve the perception of the NHCR amongst
stakeholders. However, most importantly, the need to define
health is once more emphasized due to its importance in the
assessment procedure of health effects of antioxidants and other
functional ingredients.
Although the current case study focuses on the perception of
the NHCR related to food products and functional ingredients
containing antioxidants in the Netherlands, it can easily be
extrapolated to other fields of functional ingredients and to the
situation in other Member States, since the regulation is not only
affecting functional foods containing antioxidants or solely Dutch
stakeholders but the whole European functional food market.
With highly diverging perceptions of stakeholders, the current
effectiveness of the NHCR can be questioned. The views of
different stakeholders on enforcement, methodology and impact
could help to focus the discussion on the NHCR in capturing
health effects.
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